(?R)-?,3-Dihydroxy-L-tyrosine-13C2,15N; threo-?,3-Dihydroxy-L-tyrosine-13C2,15N; L-threo-3-(3,4-Dihydroxyphenyl)serine-13C2,15N; (-)-threo-3,4-Dihydroxyphenyl-serine-13C2,15N; (2S,3R)-3-(3,4-Dihydroxyphenyl)-2-amino-3-hydroxypropanoic Acid-13C2,15N; L-DOPS-13C2,15N; L-Threodops-13C2,15N; L-threo-3,4-Dihydroxyphenyl-serine-13C2,15N; L-threo-?-(3,4-Dihydroxyphenyl)serine-13C2,15N; SM 5688-13C2,15N; threo-Dopaserine-13C2,15N;L-threo-Droxidopa-13C2,15N
L-threo-Droxidopa-13C2-15N is a fully characterized chemical compound used as a reference standard of API Dopa. The standard offered is compliant with regulatory guidelines. L-threo-Droxidopa-13C2-15N is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1276295-04-5
Related products
Levodopa EP Impurity D (3,4-Dihydroxy-D-Phenylalanine)
M.F.
M.W. 197.19
CAT# AR-D02195
CAS# 5796-17-8
Droxidopa Impurity 7-13C-d3 HCl
M.F.
M.W. 231.23 36.46
CAT# AR-D02265
CAS# 39846-91-8 (non-labelled, free base)
